Page 36 - C:\Users\ToRiM\Desktop\New folder2\
P. 36

Antimicrobial order tools can be an effective measure to decrease antimicrobial
                           consumption by implementing automatic stop orders and/or requiring clinicians to
                           justify antimicrobial use.

                           Example of Antibiotic Order Form (Appendix 7).

                      e)  Dose Optimization
                           Dose optimization will tailor therapy to the patient’s clinical characteristics, causative
                           organism,  site  of  infection,  and  pharmacokinetic  and  pharmacodynamic
                           characteristics of the antimicrobial agent.

                           Strategies that may be considered for dose optimization include:

                           •   extended  or  continuous  infusion  of  beta-lactams  (cefepime,  piperacillin/
                                 tazobactam)
                           •   once-daily dosing of aminoglycosides (gentamicin)
                           •   appropriate dosing of antimicrobials with narrow therapeutic range (vancomycin)
                           •   dosing of certain antimicrobials in special populations (obesity, pregnancy)
                           •   dose adjustments for patients with renal or liver dysfunction (polymyxins)
                           •   dose adjustments for patients with hypoalbuminemia (ertapenem)
                           •   dose adjustments for patients on renal replacement therapy

                      f)   De-escalation/ Streamlining
                           Antimicrobial streamlining or de-escalation is a process which converts broad-
                           spectrum antimicrobial therapy to a narrower-spectrum antimicrobial treatment that
                           targets a more specific organism once culture reports are available. Unnecessary
                           exposure to a broad-spectrum empirical antimicrobial treatment will increase the
                           risk of developing subsequent antimicrobial resistance.

                           Occasionally,  patients  may  be  treated  with  one  or  more  antimicrobials  before
                           causative organism is identified, where this approach is referred to as empiric
                           therapy. Empiric therapy takes into account the type of infection suspected, and the
                           patient’s clinical status. Once test and culture results are available, the antimicrobial
                           choice should be streamlined to definitive therapy based on the results.

                           De-escalation/streamlining can be typically conducted in several ways:
                           •   Review by prescribers whether empirical treatment is according to the guidelines
                                 (diagnosis, drug, dose, interval, administration route, duration). Discontinue dual
                                 antimicrobial therapy if there is overlapping in the spectrum of activity.





        34   Protocol on Antimicrobial Stewardship (AMS) Programme in Healthcare Facilities | Second Edition 2022
   31   32   33   34   35   36   37   38   39   40   41